Anelixis

Anelixis, founded in 2013, is a clinical-stage development company located in Cambridge, Massachusetts, USA. The company is a for-profit subsidiary of the ALS Therapy Development Institute, focusing on the development of immunomodulatory drugs for neurodegenerative diseases to treat Amyotrophic Lateral Sclerosis (ALS) and Alzheimer's Disease (AD).